BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 29219209)

  • 1. Warfarin use and the risk of stroke, bleeding, and mortality in older adults on dialysis with incident atrial fibrillation.
    Tan J; Bae S; Segal JB; Zhu J; Alexander GC; Segev DL; McAdams-DeMarco M
    Nephrology (Carlton); 2019 Feb; 24(2):234-244. PubMed ID: 29219209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes Associated With Apixaban Use in Patients With End-Stage Kidney Disease and Atrial Fibrillation in the United States.
    Siontis KC; Zhang X; Eckard A; Bhave N; Schaubel DE; He K; Tilea A; Stack AG; Balkrishnan R; Yao X; Noseworthy PA; Shah ND; Saran R; Nallamothu BK
    Circulation; 2018 Oct; 138(15):1519-1529. PubMed ID: 29954737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes After Warfarin Initiation in a Cohort of Hemodialysis Patients With Newly Diagnosed Atrial Fibrillation.
    Shen JI; Montez-Rath ME; Lenihan CR; Turakhia MP; Chang TI; Winkelmayer WC
    Am J Kidney Dis; 2015 Oct; 66(4):677-88. PubMed ID: 26162653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between warfarin use and incidence of ischemic stroke in Japanese hemodialysis patients with chronic sustained atrial fibrillation: a prospective cohort study.
    Wakasugi M; Kazama JJ; Tokumoto A; Suzuki K; Kageyama S; Ohya K; Miura Y; Kawachi M; Takata T; Nagai M; Ohya M; Kutsuwada K; Okajima H; Ei I; Takahashi S; Narita I
    Clin Exp Nephrol; 2014 Aug; 18(4):662-9. PubMed ID: 24113782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Warfarin use and stroke, bleeding and mortality risk in patients with end stage renal disease and atrial fibrillation: a systematic review and meta-analysis.
    Tan J; Liu S; Segal JB; Alexander GC; McAdams-DeMarco M
    BMC Nephrol; 2016 Oct; 17(1):157. PubMed ID: 27769175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness and safety of warfarin initiation in older hemodialysis patients with incident atrial fibrillation.
    Winkelmayer WC; Liu J; Setoguchi S; Choudhry NK
    Clin J Am Soc Nephrol; 2011 Nov; 6(11):2662-8. PubMed ID: 21959598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apixaban Dosing Patterns Versus Warfarin in Patients With Nonvalvular Atrial Fibrillation Receiving Dialysis: A Retrospective Cohort Study.
    Wetmore JB; Weinhandl ED; Yan H; Reyes JL; Herzog CA; Roetker NS
    Am J Kidney Dis; 2022 Nov; 80(5):569-579.e1. PubMed ID: 35469965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of oral anticoagulant therapy on mortality in end-stage renal disease patients with atrial fibrillation: a prospective study.
    Genovesi S; Rebora P; Gallieni M; Stella A; Badiali F; Conte F; Pasquali S; Bertoli S; Ondei P; Bonforte G; Pozzi C; Rossi E; Valsecchi MG; Santoro A
    J Nephrol; 2017 Aug; 30(4):573-581. PubMed ID: 27834042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in the risk of stroke, bleeding events, and mortality between female and male patients with atrial fibrillation during warfarin therapy.
    Penttilä T; Lehto M; Niiranen J; Mehtälä J; Khanfir H; Lassila R; Raatikainen P
    Eur Heart J Cardiovasc Pharmacother; 2019 Jan; 5(1):29-36. PubMed ID: 30052822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical characteristics and outcomes of dialysis patients with atrial fibrillation: the Fushimi AF Registry.
    Yamashita Y; Takagi D; Hamatani Y; Iguchi M; Masunaga N; Esato M; Chun YH; Itoh H; Nishimura M; Wada H; Hasegawa K; Ogawa H; Abe M; Akao M
    Heart Vessels; 2016 Dec; 31(12):2025-2034. PubMed ID: 26973346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stroke, Major Bleeding, and Mortality Outcomes in Warfarin Users With Atrial Fibrillation and Chronic Kidney Disease: A Meta-Analysis of Observational Studies.
    Dahal K; Kunwar S; Rijal J; Schulman P; Lee J
    Chest; 2016 Apr; 149(4):951-9. PubMed ID: 26378611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of Non-Vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Patients With Atrial Fibrillation and Valvular Heart Disease: A Systematic Review and Meta-Analysis.
    Pan KL; Singer DE; Ovbiagele B; Wu YL; Ahmed MA; Lee M
    J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28720644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Warfarin use and the risk of mortality, stroke, and bleeding in hemodialysis patients with atrial fibrillation.
    Kai B; Bogorad Y; Nguyen LN; Yang SJ; Chen W; Spencer HT; Shen AY; Lee MS
    Heart Rhythm; 2017 May; 14(5):645-651. PubMed ID: 28185918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-major bleeding with apixaban versus warfarin in patients with atrial fibrillation.
    Bahit MC; Lopes RD; Wojdyla DM; Held C; Hanna M; Vinereanu D; Hylek EM; Verheugt F; Goto S; Alexander JH; Wallentin L; Granger CB
    Heart; 2017 Apr; 103(8):623-628. PubMed ID: 27798052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness and Safety of Direct Oral Anticoagulants in an Asian Population with Atrial Fibrillation Undergoing Dialysis: A Population-Based Cohort Study and Meta-Analysis.
    See LC; Lee HF; Chao TF; Li PR; Liu JR; Wu LS; Chang SH; Yeh YH; Kuo CT; Chan YH; Lip GYH
    Cardiovasc Drugs Ther; 2021 Oct; 35(5):975-986. PubMed ID: 33211254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral Anticoagulation for Patients With Atrial Fibrillation on Long-Term Hemodialysis.
    Kuno T; Takagi H; Ando T; Sugiyama T; Miyashita S; Valentin N; Shimada YJ; Kodaira M; Numasawa Y; Briasoulis A; Burger A; Bangalore S
    J Am Coll Cardiol; 2020 Jan; 75(3):273-285. PubMed ID: 31976865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycemic status and risks of thromboembolism and major bleeding in patients with atrial fibrillation.
    Chan YH; Chuang C; Chan CC; Lee HF; Huang YC; Huang YT; Chang SH; Wang CL; Chao TF; Kuo CT; Yeh YH; Chen SA
    Cardiovasc Diabetol; 2020 Mar; 19(1):30. PubMed ID: 32156277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of atrial fibrillation with warfarin among older adults with end stage renal disease.
    Tan J; Bae S; Segal JB; Zhu J; Segev DL; Alexander GC; McAdams-DeMarco M
    J Nephrol; 2017 Dec; 30(6):831-839. PubMed ID: 28120282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and Safety of Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation and Chronic Kidney Disease Stage G4: A Single-Center Experience.
    Heleniak Z; Papuga-Szela E; Krzysztof P; Anetta U
    J Cardiovasc Pharmacol; 2020 Dec; 76(6):671-677. PubMed ID: 33284572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Warfarin Use, Stroke, and Bleeding Risk among Pre-Existing Atrial Fibrillation US Veterans Transitioning to Dialysis.
    Sy J; Wenziger C; Marroquin M; Kalantar-Zadeh K; Kovesdy C; Streja E
    Nephron; 2022; 146(4):360-368. PubMed ID: 35124673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.